Brief: Acadia Pharmaceuticals Q4 EPS USD 0.86 Vs. IBES Estimate USD 0.22
26/02/2025 21:05
Feb 26 (Reuters) - Acadia Pharmaceuticals Q4 net income USD 143.742 million vs. IBES estimate USD 40.8 million. Q4 operating expenses USD 106.099 million Q4 pretax profit USD 161.085 million vs. IBES estimate USD 45.3 million Q4 product sales USD 259.602 million vs. IBES estimate USD 277.7 million
Recent news on Acadia Pharmaceuticals
See all newsUS RESEARCH ROUNDUP-Chevron, Exxon Mobil, GoDaddy
U.S. STOCKS ON THE MOVE-Charles River, Oracle, TD Synnex
US STOCKS ON THE MOVE-Charles River, Oracle, TD Synnex
Acadia's Alzheimer's psychosis drug misses main goal of mid-stage study (updated)
U.S. STOCKS ON THE MOVE-CoreWeave, Versant Media, BlackBerry